SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 20.88 | 19.89 | 19.51 | 5.07 | 3.72 |
What is the latest Profit After Tax (PAT) Margin ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 20.88 |
| Mar2024 | 19.89 |
| Mar2023 | 19.51 |
| Mar2022 | 5.07 |
| Mar2021 | 3.72 |
How is Profit After Tax (PAT) Margin of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 20.88 | 4.98 | |
| Mar2024 | 19.89 | 1.95 | |
| Mar2023 | 19.51 | 284.81 | |
| Mar2022 | 5.07 | 36.29 | |
| Mar2021 | 3.72 | - | |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,927.2 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
| MANKIND PHARMA | ₹96,492.8 Cr | 0.7% | -1.1% | -4.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% |
-3.6% |
6% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses